Defunct Company
Total Trials
4
As Lead Sponsor
1
As Collaborator
3
Total Enrollment
313
NCT00653952
CAELYX Versus Paclitaxel HCl in Patients With Epithelial Ovarian Carcinoma Following Failure of First-Line, Platinum-Based Chemotherapy
Phase: Phase 3
Role: Collaborator
Start: May 31, 1997
Completion: Apr 30, 2000
NCT00003225
Amifostine Plus Irinotecan in Treating Patients With Metastatic Colorectal Cancer
Phase: Phase 1/2
Start: Jul 31, 1997
Completion: Jun 30, 2001
NCT00003827
Combination Chemotherapy in Treating Patients With Myelodysplastic Syndrome
Phase: Phase 2
Role: Lead Sponsor
Start: Jan 31, 1999
Completion: Not specified
NCT00177281
Safety Study of S-CKD602 in Patients With Advanced Malignancies
Phase: Phase 1
Start: Sep 30, 2003
Completion: May 31, 2006